Antitubercular Therapy Given to Differentiate Crohn's Disease From Intestinal Tuberculosis Predisposes to Stricture Formation
- 1 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 14 (11), 1611-1618
- https://doi.org/10.1093/ecco-jcc/jjaa091
Abstract
Background and Aim: Treatment trial with antitubercular therapy [ATT] is a common strategy in tuberculosis-endemic countries in case of a diagnostic dilemma between intestinal tuberculosis and Crohn's disease [CD]. Our aim was to determine the long-term clinical course of patients who received ATT before an eventual diagnosis of CD was made. Methods: We performed retrospective comparison between CD patients who received >= 6 months of ATT vs those who did not receive ATT. Outcomes assessed were change in disease behaviour during follow-up, requirement of surgery and medication use. Results: In all, 760 patients with CD were screened for the study and, after propensity matching for location and behaviour of disease, 79 patients in each group were compared. Progression from inflammatory [B1] to stricturing/fistulising [B2/B3] phenotype was increased among CD patients who received ATT [61, 62, B3: 73.4%, 26.6%, 0% at baseline vs: 41.8%, 51.9%, 6.3% at follow-up, respectively] as compared with those who did not receive ATT [B1, B2, B3: 73.4%, 26.6%, 0% at baseline vs: 72.2%, 27.8%, 0% at follow-up, respectively] with an odds ratio of 11.05[3.17-38.56]. The usage of 5-aminosalocylates, steroids, immunosuppressants and anti-tumour necrosis factor was similar between both the groups. On survival analysis, CD patients who received ATT had a lower probability of remaining free of surgery 145%] than those who did not [76%] at 14 years of follow-up (hazard ratio [HR] = 3.22, 95% confidence interval [CI], 1.46-7.12, p= 0.004]. Conclusions: Crohn's disease patients diagnosed after a trial with antitubercular therapy had an unfavourable long-term disease course with higher rate of stricture formation and less chance of remaining free of surgery.Funding Information
- Indian Council of Medical Research-Center
This publication has 19 references indexed in Scilit:
- Temporal Change in Phenotypic Behaviour in Patients with Crohn’s Disease: Do Indian Patients Behave Differently from Western and Other Asian Patients?Journal of Crohn's and Colitis, 2015
- Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiologyJournal of Gastroenterology and Hepatology, 2015
- Is it Possible to Change Phenotype Progression in Crohn's Disease in the Era of Immunomodulators? Predictive Factors of Phenotype ProgressionThe American Journal of Gastroenterology, 2014
- Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based CohortGastroenterology, 2010
- Clinical, Endoscopic, and Histological Differentiations Between Crohn's Disease and Intestinal TuberculosisThe American Journal of Gastroenterology, 2010
- The Natural History of Adult Crohn's Disease in Population-Based CohortsThe American Journal of Gastroenterology, 2010
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- European evidence based consensus on the diagnosis and management of Crohn's disease: current managementGut, 2006
- Natural History and Clinical Behavior of Crohn's Disease Extending Beyond Two DecadesJournal of Clinical Gastroenterology, 2003
- Controlled trial of antimycobacterial therapy in Crohn's diseaseDigestive Diseases and Sciences, 1991